Doheny Asset Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Doheny Asset Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23	Closed	-$35K	–	102
2021 Q2	$35K	Sell	23 -182	-89%	-$396K	0.02%	97
2021 Q1	$550K	Buy	205 +64	+45%	+$127K	0.37%	65
2020 Q4	$278K	Sell	141 -55	-28%	-$129K	0.19%	89
2020 Q3	$529K	Buy	196 +84	+75%	+$209K	0.44%	55
2020 Q2	$319K	Buy	112 +73	+187%	+$235K	0.3%	68
2020 Q1	$99K	Hold	39	–	–	0.08%	96
2019 Q4	$99K	Buy	+39	New	+$50.8K	0.08%	96

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Doheny Asset Management's APTO Position: Q3 2021 in Review

Doheny Asset Management sold out of Aptose Biosciences, Inc. (APTO) in Q3 2021, closing a stake of 23 shares — an estimated $35K sold.

Doheny Asset Management first reported a position in APTO in Q4 2019 and held it in 7 quarters. The position peaked at $550K in Q1 2021. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2021.

Doheny Asset Management reported no remaining Aptose Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Doheny Asset Management sold 23 Aptose Biosciences, Inc. shares in Q3 2021, an estimated $35K.
Doheny Asset Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 7 quarters.
Doheny Asset Management's Aptose Biosciences, Inc. position peaked at $550K in Q1 2021.
64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2021.

Based on Doheny Asset Management's 13F filing for Q3 2021, filed 22 Oct 2021.